 The main reasons for continuing the search for new NRTIs against HIV-1 are to decrease toxicity, increase efficiency against resistant viruses, and simplify anti-HIV-1 treatment.Apricitabine is a deoxycytidine analogue.It is structurally related to lamivudine where the positions of the oxygen and the sulfur are essentially reversed.